Accelrys Continues to Expand Breadth of Product Offerings Optimized For IBM Servers Wide Range of Accelrys Life Sciences Informatics Applications Now Available On

IBM Systems, Including RS3 - Leading Oracle-Based Cheminformatics Database



    SAN DIEGO, April 8 /PRNewswire-FirstCall/ -- Accelrys Inc. today announced
 the commercial availability of five additional Accelrys software applications
 on IBM eServer* pSeries* systems running AIX*.  This is the second group of
 product releases resulting from the global strategic alliance between IBM and
 Accelrys that was announced in January of this year.  The alliance seeks to
 enhance drug research and development (R&D) operations by creating a
 collaborative information technology environment to help chemists and
 biologists develop new drugs faster, more efficiently, and at lower costs.
     "This new milestone reflects the commitment and aggressive timetable IBM
 and Accelrys have set to deliver innovative information technologies through
 our alliance," said Mike Svinte, vice president of Worldwide Business
 Development, IBM Life Sciences.  "We have now enabled ten of Accelrys' leading
 life sciences applications to run optimally on IBM's servers, and more
 applications are in the pipeline.  This is good news for customers who need
 powerful solutions to improve the efficiency of their pharmaceutical R&D
 operations."
     The second set of Accelrys applications optimized to run on IBM eServer
 pSeries systems, including the new p690 server code named "Regatta," are RS3,
 CNX, and HypoGen, HipHop, and Confirm from the Catalyst(R) suite.  These
 additional applications broaden Accelrys' suite of IBM ported applications to
 a total of ten diversified products with functionalities supporting
 bioinformatics, cheminformatics, modeling, and analytics.  Over the next three
 quarters of 2002, Accelrys will continue to collaborate with IBM to migrate
 and optimize the majority of its top life sciences applications on IBM
 systems.
     "We recognize that innovation and efficiency are critical to drug
 discovery and development and are very pleased to offer an expanded group of
 Accelrys products on the IBM eServer pSeries ahead of schedule," said Dr.
 Scott Kahn, general manager and senior vice president of Life Science for
 Accelrys.  "Our successful alliance with IBM and our aggressive timetable
 enable us to stay a step ahead of our customers' needs and expectations."
     Products ported to the IBM platform will initially operate on AIX servers
 and will be designed to seamlessly integrate into the upcoming Discovery
 Studio(TM) enterprise client-server environment.  In addition, Accelrys
 products that are Discovery Studio enabled will be available on a range of
 server environments, including AIX and other proprietary versions of UNIX(TM)
 as well as Windows NT and Linux.  The product roadmaps have been specifically
 designed and licensed to facilitate the transition from an isolated
 workstation environment to a collaborative enterprise computing model,
 recognizing the need to maintain data integrity, full application access and
 the ability to scale and deploy high-performance compute resources
 dynamically.
 
     About Accelrys Inc.
     Accelrys is a leading provider of software for computation, simulation,
 and the management and mining of scientific data used by biologists, chemists,
 and materials scientists for product design, drug discovery, and development.
 Accelrys' platform technology and consulting services enable enterprise-wide
 solutions tailored to today's leading research organizations.  The company's
 three main centers of excellence are in San Diego, CA, Princeton, NJ, and
 Cambridge, UK. These centers combine research and product development with
 facilities to support significant collaborative projects.  Accelrys is a
 subsidiary of Pharmacopeia, Inc. (Nasdaq:   PCOP) and was launched in June 2001,
 combining leading software companies Molecular Simulations Inc., Synopsys
 Scientific Systems, Oxford Molecular, GCG, and Synomics Ltd.
     More information on Accelrys can be found at http://www.accelrys.com.
 
     Catalyst is a registered trademark of Accelrys Inc. within the United
 States and/or various other countries.  Discovery Studio is a trademark of
 Accelrys Inc. within the United States and/or various other countries.
 
     * Indicates trademark or registered trademark of IBM Corporation.
 eServer, pSeries and AIX are registered trademarks of IBM Corporation.
     UNIX is a registered trademark in the United States and other countries
 licensed exclusively through The Open Group.
 
      CONTACT:  Jim Rivas of Accelrys, +1-858-799-5393, or jrivas@accelrys.com
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X34688659
 
 

SOURCE Accelrys, Inc.

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.